Search

Search Constraints

You searched for: Author/Creator van Dyck, Christopher H.

Search Results

11. Cerebrospinal fluid and brain PET measures of synaptic density glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's disease. (31st December 2021)

12. Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study. Issue 9 (11th August 2017)

13. Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis. (30th November 2021)

14. Comparing three methods of computerised cognitive training for older adults with subclinical cognitive decline. Issue 5 (2nd September 2016)

15. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies. Issue 1 (22nd February 2019)

17. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Issue 6 (21st March 2015)

18. Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD. (7th December 2020)

19. Generation of synthetic PET images of synaptic density and amyloid from 18F‐FDG images using deep learning. Issue 9 (27th July 2021)

20. ICA‐derived sources of synaptic density PET ([11C]UCB‐J) relate to cognitive impairment severity in Alzheimer's disease: Neuroimaging: Imaging the human synapse in AD. (7th December 2020)